Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: The Rotterdam Study

Lancet

Volumn 351, Issue 9119, 1998, Pages 1840-1843

  Ott, A ^a   Slooter, A J C ^a   Hofman, A ^a   Van Harskamp, F ^a   Witteman, J C M ^a   Van Broeckhoven, C ^b   Van Duijn, C M ^a   Breteler, M M B ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4;

ADULT; AGED; ALCOHOL CONSUMPTION; ALZHEIMER DISEASE; ARTICLE; CASE CONTROL STUDY; CIGARETTE SMOKING; CONTROLLED STUDY; DEMENTIA; EDUCATION; FEMALE; FOLLOW UP; GENOTYPE; HUMAN; MALE; MATHEMATICAL MODEL; NORMAL HUMAN; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK; SMOKING;

EID: 0032551222     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)07541-7     Document Type: Article

References (29)

1. 1 Ott A, Breteler MMB, Van Harskamp F, et al. Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam study. BMJ 1995; 310: 970-73.
2. 2 Bartecchi CE, MacKenzie TD, Schrier RW. The human costs of tobacco use (1). N Engl J Med 1994; 330: 907-12.
3. 3 Shinton R, Beevers G. Meta-analysis of the relation between cigarette smoking and stroke. BMJ 1989; 298: 789-94.
4. 4 Cruickshank JM, Neil-Dwyer G, Dorrance DE, Hayes Y, Patel S. Acute effects of smoking on blood pressure and cerebral blood flow. J Hum Hypertens 1989; 3: 443-49.
5. 5 Thomas T, Thomas G, McLendon C, Sutton T, Mullan M. β-amyloid-mediated vasoactivity and vascular endothelial damage. Nature 1996; 380: 168-71.
6. 6 Hofman A, Ott A, Breteler MMB, et al. Atherosclerosis, apolipoprotein E, and the prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet 1997; 349: 151-54.
7. 7 Hachinski VC. Preventable senility: a call for action against the vascular dementias. Lancet 1992; 340: 645-48.
8. 8 Lee PN. Smoking and Alzheimer's disease: a review of the epidemiological evidence. Neuroepidemiology 1994; 13: 131-44.
9. 9 Van Duijn CM, Havekes LM, Van Broeckhoven C, De Knijff P, Hofman A. Apolipoprotein E genotype and association between smoking and early onset Alzheimer's disease. BMJ 1995; 310: 627-31.
10. 10 Riggs JE. Smoking and Alzheimer's disease: protective effect or differential survival bias? Lancet 1993; 342: 793-94.
11. 11 Doll R, Peto R, Wheatly K, Gray R, Sutherland I. Mortality in relation to smoking: 40 years' observations on male British doctors. BMJ 1994; 309: 901-11.
12. 12 Hofman A, Grobbee DE, De Jong PTVM, Van den Ouweland FA. Determinants of disease and disability in the elderly. The Rotterdam Elderly Study. Em J Epidemiol 1991; 7: 403-22.
13. 13 Ott A, Breteler MMB, van Harskamp F, Stijnen T, Hofman A. The incidence and risk of dementia. The Rotterdam Study. Am J Epidemiol 1998; 147: 574-80.
14. 14 Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiat Res 1975; 12: 189-98.
15. 15 Copeland JRM, Keleher MJ, Kellet JM, et al. A semi-structured clinical interview for the assessment of diagnosis and mental state in the elderly. The Geriatric Mental State Schedule I. Development and reliability. Psychol Med 1976; 6: 439-49.
16. 16 American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 3rd edn, rev. Washington DC: American Psychiatric Association, 1987.
17. 17 McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-44.
18. 18 Roman GC, Tatemichi TK, ErkinjunttiT, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993; 43: 250-60.
19. 19 Geleijnse JM, Witteman JC, den Breeijen JH, et al. Dietary electrolyte intake and blood pressure in older subjects: the Rotterdam Study. J Hypertens 1996; 14: 737-41.
20. 20 Wenham PR, Price WH, Blundell G. Apolipoprotein E genotyping by one-stage PCR. Lancet 1991; 337: 1158-59.
21. 21 Orgogozo JM, Dartigues JF, Lafont S, et al. Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area. Rev Neurol (Paris) 1997; 153: 185-92.
22. 22 Meyer JS, McClintic KL, Rogers RL, Sims P, Mortel KF. Actiological considerations and risk factors for multi-infarct dementia. J Neurol Neurosurg Psychiatry 1988; 51: 1489-97.
23. 23 Gorelick PB, Brody J, Cohen D, et al. Risk factors for dementia associated with multiple cerebral infarcts. A case-control analysis in predominantly African-American hospital-based patients. Arch Neurol 1993; 50: 714-20.
24. 24 Hebert LE, Scherr PA, Beckett LA, et al. Relation of smoking and alcohol consumption to incident Alzheimer's disease. Am J Epidemiol 1992; 135: 347-55.
25. 25 Brenner DE, Kukull WA, van Belle G, et al. Relationship between cigarette smoking and Alzheimer's disease in a population-based case-control study. Neurology 1993; 43: 293-300.
26. 26 Prince M, Cullen M, Mann A. Risk factors for Alzheimer's disease and dementia: a case-control study based on the MRC elderly hypertension trial. Neurology 1994; 44: 97-104.
27. 27 Yoshitake T, Kiyohara Y, Kato I, et al. Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study. Neurology 1995; 45: 1161-68.
28. 28 Wilson PWF, Schaefer EJ, Larson MG, Ordovas JM. Apolipoprotein E alleles and risk of coronary disease: a meta-analysis. Arteriosder Thromb Vasc Biol 1996; 16: 1250-55.
29. 29 Poirier J, Delisle M-C, Quirion R, et al. Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease. Proc Natl Acad Sci USA 1995; 92: 12260-64.